In vitro and in vivo characterization of the bifunctional μ and δ opioid receptor ligand UFP‐505

Author:

Dietis N1ORCID,Niwa H1,Tose R1,McDonald J1,Ruggieri V2,Filaferro M3,Vitale G4,Micheli L5,Ghelardini C5,Salvadori S6,Calo G6ORCID,Guerrini R7,Rowbotham D J8,Lambert D G1ORCID

Affiliation:

1. Department of Cardiovascular SciencesUniversity of Leicester, Division of Anaesthesia, Critical Care and Pain Management, Leicester Royal Infirmary Leicester UK

2. Department of Oncology Haematology and Respiratory DiseasesUniversity of Modena and Reggio Emilia Modena Italy

3. Department of Biomedical, Metabolic and Neuro‐SciencesUniversity of Modena and Reggio Emilia Modena Italy

4. Section of Pharmacology, Department of Life SciencesUniversity of Modena and Reggio Emilia Modena Italy

5. Department of Preclinical and Clinical PharmacologyUniversity of Florence Florence Italy

6. Department of Experimental and Clinical Medicine, Section of PharmacologyUniversity of Ferrara Ferrara Italy

7. Department of Pharmaceutical SciencesUniversity of Ferrara Ferrara Italy

8. Department of Health SciencesUniversity of Leicester, Division of Anaesthesia, Critical Care and Pain Management, Leicester Royal Infirmary Leicester UK

Funder

HOPE Against Cancer

Publisher

Wiley

Subject

Pharmacology

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3